A restructuring of microbiome niche space is associated with Elexacaftor-Tezacaftor-Ivacaftor therapy in the cystic fibrosis lung(✩)

por Sosinski, Lo M., Christian, Martin H, Neugebauer, Kerri A., Ghuneim, Lydia-Ann J., Guzior, Douglas V., Castillo-Bahena, Alicia, Mielke, Jenna, Thomas, Ryan, McClelland, Marc, Conrad, Doug, Quinn, Robert A.
Publicado 2022